← Leaderboards
Aron S Buchman
Rush University Medical Center
$27,290,421
Attributed
$31,087,649
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,087,649 · 11
By mechanism
R01$30,330,113 · 10
R56$757,536 · 1
Top collaborators
- Andrew Lim4 shared
- Veronique Vanderhorst4 shared
- Hans-Ulrich Klein1 shared
- Michal Schnaider Beeri1 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Julie A Schneider$29,310,501
- David A Bennett$145,760,843
- Lisa L Barnes$44,877,971
- Melissa Lamar$7,342,573
- Laura Tran$92,788
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAgingMemoryPathologyCessation Of LifeSpinal CordIndexingElderlyMotorAdultBrainPathologicAffectGaitDementiaS DiseaseParticipantAutopsyBaseImpairmentCognitionCognitiveResourcesBrain Region
Grant awards (46)
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain$1,367,799
R01 · FY2025 · AG · contact PI
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults$1,171,721
R01 · FY2025 · AG
Decoding the role of the glycoproteome in Alzheimerâs disease and related disorders.$795,436
R01 · FY2025 · AG
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?$738,585
R01 · FY2025 · AG · contact PI
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain$1,426,500
R01 · FY2024 · AG · contact PI
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?$698,969
R01 · FY2024 · AG · contact PI
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain$1,470,851
R01 · FY2023 · AG · contact PI
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults$1,202,702
R01 · FY2023 · AG
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?$713,469
R01 · FY2023 · AG · contact PI
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimerâs disease and related disorders$663,310
R01 · FY2023 · AG · contact PI
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain$1,354,497
R01 · FY2022 · AG · contact PI
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults$1,232,581
R01 · FY2022 · AG
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimerâs disease and related disorders$697,563
R01 · FY2022 · AG · contact PI
Thinking about walking: Can digital phenotyping of mobility improve the prediction of Alzheimer's dementia and inform on the pathologies and proteins contributing to this association?$582,737
R01 · FY2022 · AG · contact PI
Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults$1,293,402
R01 · FY2021 · AG
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders$657,080
R01 · FY2021 · AG · contact PI
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimerâs disease and related disorders$46,314
R01 · FY2021 · AG · contact PI
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimerâs disease and related disorders$711,340
R01 · FY2020 · AG · contact PI
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders$677,490
R01 · FY2020 · AG · contact PI
Elucidating the molecular drivers of impaired mobility within and outside the CNS in Alzheimerâs disease and related disorders$711,340
R01 · FY2019 · AG · contact PI
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders$697,900
R01 · FY2019 · AG · contact PI
Spinal cord and brainstem pathology contributions to late-life gait impairment$533,364
R01 · FY2019 · AG · contact PI
Elucidating the Molecular Drivers of Impaired Mobility Within and Outside the CNS in Alzheimer's Disease and Related Disorders$757,536
R56 · FY2018 · AG · contact PI
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders$719,880
R01 · FY2018 · AG · contact PI
Spinal cord and brainstem pathology contributions to late-life gait impairment$553,340
R01 · FY2018 · AG · contact PI
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related Disorders$760,035
R01 · FY2017 · AG · contact PI
Spinal cord and brainstem pathology contributions to late-life gait impairment$512,570
R01 · FY2017 · AG · contact PI
The Clinical Profile of Parkinson's Disease (PD) Pathology$485,887
R01 · FY2016 · NS · contact PI
Spinal cord and brainstem pathology contributions to late-life gait impairment$431,933
R01 · FY2016 · AG · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$313,650
R01 · FY2016 · AG · contact PI
Spinal cord and brainstem pathology contributions to late-life gait impairment$569,239
R01 · FY2015 · AG · contact PI
The Clinical Profile of Parkinson's Disease (PD) Pathology$461,882
R01 · FY2015 · NS · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$304,240
R01 · FY2015 · AG · contact PI
The Clinical Profile of Parkinson's Disease (PD) Pathology$460,867
R01 · FY2014 · NS · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$313,650
R01 · FY2014 · AG · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$175,555
R01 · FY2014 · AG · contact PI
The Clinical Profile of Parkinson's Disease (PD) Pathology$472,918
R01 · FY2013 · NS · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$296,399
R01 · FY2013 · AG · contact PI
The Clinical Profile of Parkinson's Disease (PD) Pathology$489,893
R01 · FY2012 · NS · contact PI
Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment$313,650
R01 · FY2012 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$778,776
R01 · FY2009 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$759,502
R01 · FY2008 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$496,803
R01 · FY2007 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$212,985
R01 · FY2007 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$516,255
R01 · FY2006 · AG · contact PI
Risk Factors and the Neurobiologic Substrate of Frailty$485,254
R01 · FY2005 · AG